Breaking News
October 23, 2018 - Juul Drawing Lots of Teen Followers on Twitter
October 23, 2018 - WHO says Zika risk low in Pacific ahead of Meghan visit
October 23, 2018 - A deeper look at ‘Reflecting Frankenstein’
October 23, 2018 - Breastfeeding can have protective affect against high blood pressure in women, confirms study
October 23, 2018 - Epigenetic modifications may contribute to Alzheimer’s Disease
October 23, 2018 - Volunteering for peer counseling programs benefits people with lupus
October 23, 2018 - Cancer treatment may undergo a paradigm shift to immunotherapy soon
October 23, 2018 - Study uncovers new mechanism of action in a first-line drug for diabetes
October 23, 2018 - New type of molecule shows early promise against treatment-resistant prostate cancer
October 23, 2018 - Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients
October 23, 2018 - Scientists grow functioning human neural networks in 3D from stem cells
October 23, 2018 - Using mushrooms as a prebiotic may help improve glucose regulation
October 23, 2018 - New ENT clinic treats children in Zimbabwe
October 23, 2018 - CUIMC Celebrates 2018-2019, Issue 2
October 23, 2018 - Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer
October 23, 2018 - Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage
October 23, 2018 - Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics
October 23, 2018 - Lowering systolic blood pressure does not damage the kidneys, shows study
October 23, 2018 - Incyte Announces Positive Data from Phase 2b Trial of Ruxolitinib Cream in Patients with Atopic Dermatitis
October 23, 2018 - Cardiovascular admissions more common among most deprived
October 23, 2018 - Targeted drug and hormone therapy combination extends breast cancer survival
October 23, 2018 - Map of human liver cells reveals molecular make-up of individual cells
October 23, 2018 - Drugs approved for breast cancer treatment are effective and well tolerated in men
October 23, 2018 - EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring
October 23, 2018 - Researchers identify common genetic connection in lung conditions
October 23, 2018 - Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC
October 23, 2018 - Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer
October 23, 2018 - New discovery may lead to better treatment options for pancreatic cancer patients
October 23, 2018 - FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma
October 23, 2018 - Researchers identify immune culprits linked to inflammation and bone loss in gum disease
October 23, 2018 - Despite lower risk factors, black men have higher rates of recidivism
October 23, 2018 - Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery
October 23, 2018 - AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis
October 23, 2018 - NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors
October 23, 2018 - Scientists use electron microscope to study chemical transformation in catalytic cross-coupling reaction
October 23, 2018 - Research offers new hope to men who received childhood cancer treatment
October 23, 2018 - New medical navigation system receives international innovation award
October 23, 2018 - Adverse Childhood Experiences Tied to Burnout in BSN Students
October 23, 2018 - High levels of oral disease among elite athletes affecting performance
October 23, 2018 - Study examines effect of immediate vs delayed pushing during labor on delivery outcomes
October 23, 2018 - LU-RRTC to spearhead capacity-building efforts for racial and ethnic populations
October 23, 2018 - Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients
October 23, 2018 - Organic food may protect against cancers finds study
October 23, 2018 - Interweaving anxiety disorder associated with stuttering remains unrecognized
October 23, 2018 - Cannabis oil shown to significantly improve Crohn’s disease symptoms
October 23, 2018 - Knowledge of sex differences in lower urinary tract may help stimulate breakthroughs in diagnosis, management
October 23, 2018 - Common antibodies associated with myocardial infarction
October 23, 2018 - Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy
October 23, 2018 - Brain’s ‘Self-Control’ Center May Be Key to Weight-Loss Success
October 23, 2018 - Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death
October 23, 2018 - Can virtual reality help people become more compassionate?
October 23, 2018 - Screen time eclipsed outdoor time for most students, shows study
October 23, 2018 - SLU researcher seeks to find solutions for ‘chemo brain’ symptoms and side effects of opioids
October 23, 2018 - Plastics now commonly found in human stools
October 23, 2018 - Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
Young drinkers underestimate the effects of supersized alcopops, shows study

Young drinkers underestimate the effects of supersized alcopops, shows study

image_pdfDownload PDFimage_print

College students seriously underestimate the effects of drinking a new class of beverages being marketed across the country, according to a new George Mason University study. “Supersized alcopops” – sweet, colorful and fizzy drinks that have been shown to appeal to youth – now contain almost as much alcohol as a six-pack of beer in a single can, and young drinkers don’t know how much these drinks can affect them.

The new study, published in Alcoholism: Clinical and Experimental Research, randomized Mason students into two groups, and asked each group to estimate what their blood alcohol concentration (BAC) would be if they hypothetically consumed over the course of 2 hours 1, 2, or 3 cans of the product shown to them: an empty can of either supersized alcopop or of regular beer. They were also asked how many cans they could drink before it would be unsafe for them to drive.

Students estimating the effects of supersized alcohol consistently underestimated the impact of these high-alcohol beverages. While students tended to overestimate how drunk they would be from drinking beer, they consistently underestimated the level of intoxication they would reach by drinking the supersized alcopop. Researchers used information about students’ sex and weight to calculate their BACs at different levels of consumption for each product. Compared to those making estimates based on beer consumption, those estimating the effects of supersized alcopops had 7 times the odds of having a calculated BAC of 0.08 g/dL or higher before they thought it would be unsafe for them to drive.

“These new products constitute a unique danger to youth,” according to study lead Dr. Matthew Rossheim, an assistant professor of global and community health in Mason’s College of Health and Human Services. “Yet our findings clearly show that young people are not getting the message about how much they can be affected by them.”

The Federal Trade Commission has stated that consuming one can of supersized alcopop during a single occasion constitutes binge drinking and is therefore an unsafe practice. Youth have presented to emergency departments with BACs as high as 0.40 g/dL after consuming supersized alcopops – 5 times the legal driving limit for adults. This potentially lethal dose of alcohol could be achieved by consuming just two supersized alcopops in two hours.

At the federal level and in most states, these products are classified as beer, which generally gives them a lower tax rate and availability in a wider array of stores than distilled spirits. In a companion commentary published on-line last month by The American Journal of Drug and Alcohol Abuse, Rossheim and colleagues calculated how much alcohol would actually have to come from a malt base in order for the products to reach their new alcohol level of 14%. “In order for supersized alcopops to be correctly classified as beer under current law, the beer base of these products would need to have an extraordinarily high alcohol-by-volume- at least 13% and likely much higher,” Rossheim said. “This appears to be unlikely given the much lower retail price per volume of supersized alcopops compared to beers with similar alcohol-by-volume.”

Flavored alcoholic beverages like these supersized alcopops have a history of non-compliance with laws defining beer as a category. The extremely high alcohol-by-volume and low price of supersized alcopops suggest that the new products are even more likely to be non-compliant with these laws.

This potential misclassification would result in manufacturers evading paying appropriate federal and state taxes. Moreover, it may be making large quantities of alcohol even more affordable and accessible to underage youth. According to Rossheim, “From a public safety perspective, it is urgently important that the Alcohol and Tobacco Tax and Trade Bureau assess the formulation of supersized alcopops to determine its correct legal classification.”

Alcohol continues to be the leading drug used by youth, and is responsible for 4,300 deaths each year of people under 21. It is second only to illicit/prescription drug use as the leading cause of death and disability among people aged 15 to 49, and causes 1 in 10 deaths of persons of working age.

In 2015, 17 state attorneys general sent a letter to the manufacturer of Four Loko–the brand of supersized alcopop most commonly consumed by underage youth–formally requesting that the alcohol concentration be voluntarily reduced. The company did not comply with their request. To the contrary, they now offer five additional flavors with even greater alcohol content. Rossheim stated, “In the absence of voluntary actions by these manufacturers to reduce the alcohol content of these products, government regulatory action is urgently needed.”

Source:

https://chhs.gmu.edu/news/513021

Tagged with:

About author

Related Articles